Martin Alexander Gershon

Managing Partner · Endeavor Venture Funds · New York, United States

Decision maker

Email

Verified, deliverable email

Endeavor Life Science Venture Funds is a Series B evergreen fund and Seed and Series A Venture Studio.

Stages: Series A, Seed, Pre-seed
Sectors: Health tech
Cheque size: €460k–€23M
Location: New York, United States
Freshness: Verified today

Notable investments

QuantHealthLeadSeries A · $2.5M · 2023
Viome Life SciencesLeadSeries C · $10M · 2023
FertifaLeadSeed · $650K · 2023
Alto NeuroscienceLeadSeries B · $7M · 2023
PVmedLeadSeries B · $70K · 2022
BehaVRLeadSeries B · $1M · 2022
SaVia HealthLeadSeed · $1M · 2022
CardiosenseLeadSeries A · $3M · 2022

Frequently co-invests with

Adam KnightChristian AngermayerPresight CapitalCris De LucaSanofi VenturesDaniel GottliebBroadview VenturesDeepali NangiaSpeedinvestEileen BurbidgePassion CapitalEnke BashllariArkitekt VenturesEric KingIntel CapitalIttai HarelPitango Venture CapitalItxaso del PalacioNotion CapitalJeff TerrellHatteras Venture PartnersJen ArdIntel Capital

Related lists

Health tech investors Series A Health tech in United States Seed Health tech in United States Pre-seed Health tech in United States

Similar investors

Rishi GuptaPartner, OrbiMed

Ralph (Chris) ChristoffersenPartner, Morgenthaler Ventures

Blake PateAnalyst, Bios Partners

Raj ParekhGeneral Partner, Advent Life Sciences

Reinhard VogtVenture Partner, Dynamk Capital

Richard WellsManaging Director, Insight Partners

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Martin Alexander Gershon? Request removal of this listing.